Cipla gets EIR from USFDA for Kurkumbh facility
The Kurkumbh manufacturing facility was inspected by the United States Food and Drug Administration (USFDA) from March 11 to March 20, 2019, Cipla said in a BSE filing.
Cipla has received EIR from the US health regulator after inspection of Kurkumbh facility in Maharashtra, Photo: Reuters